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The SEARCH for Diabetes in Youth (SEARCH) study was initiated in 2000, with
funding from the Centers for Disease Control and Prevention and support from the
National Institute of Diabetes andDigestive and Kidney Diseases, to addressmajor
knowledge gaps in the understanding of childhood diabetes. SEARCH is being
conducted at five sites across the U.S. and represents the largest, most diverse
study of diabetes among U.S. youth. An active registry of youth diagnosed with
diabetes at age <20 years allows the assessment of prevalence (in 2001 and 2009),
annual incidence (since 2002), and trends by age, race/ethnicity, sex, and diabetes
type. Prevalence increased significantly from 2001 to 2009 for both type 1 and
type 2 diabetes in most age, sex, and race/ethnic groups. SEARCH has also
established a longitudinal cohort to assess the natural history and risk factors
for acute and chronic diabetes-related complications as well as the quality of care
and quality of life of persons with diabetes from diagnosis into young adulthood.
Many youth with diabetes, particularly those from low-resourced racial/ethnic
minority populations, are notmeeting recommended guidelines for diabetes care.
Markers of micro- and macrovascular complications are evident in youth with
either diabetes type, highlighting the seriousness of diabetes in this contemporary
cohort. This review summarizes the study methods, describes key registry and
cohort findings and their clinical and public health implications, and discusses
future directions.
Significant gaps existed at the start of the 21st century in our understanding of
diabetes in youth, including limited data on the burden of diabetes and trends in
incidence and prevalence by type, age, sex, and race/ethnicity, the natural history
and etiologic classification of childhood diabetes, the burden and risk factors for
diabetes-related early complications, and the quality of health care and quality of
life of youth with diabetes. The SEARCH for Diabetes in Youth (SEARCH) study was
initiated in 2000 with funding from the Division of Diabetes Translation of the
Centers for Disease Control and Prevention and the National Institute of Diabetes
and Digestive and Kidney Diseases of the National Institutes of Health to address
these gaps and respond to emerging issues in the field of childhood diabetes.
SEARCH has brought together multiple facets of childhood diabetes research: an
active epidemiologic surveillance component to assess trends in incidence, preva-
lence, and clinical course and a health services research component to evaluate the
processes and quality of care using both clinical and public health perspectives. We
provide a description of themethods used and an overview ofmajor findings to date
as well as future questions and challenges to be addressed to develop a more
complete picture of diabetes in youth.
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Phase 1 (2000–2005) (1) and 2 (2005–
2010) included six recruitment centers,
four geographic-based sites based in
Ohio (eight counties including Cincin-
nati, OH); the entire state of Colorado;
five counties around Seattle, Washing-
ton; the entire state of South Carolina;
two health plan–based sites in Hawaii
and California (health plan enrollees in
one plan from seven counties); and un-
der the direction of Colorado, American
Indian reservation-based populations in
Arizona and NewMexico. Each site iden-
tified prevalent (in 2001 and 2009) and
incident cases (ongoing since 2002) of
diagnosed diabetes (excluding gesta-
tional diabetes) in youth ,20 years of
age. Phase 3 began in 2010 and contin-
ues to the present with five of the six
original centers (excluding Hawaii).
Study Components
SEARCH includes a registry and a cohort
study (Fig. 1). The registry study identi-
fies incident cases each year since 2002
through the present with ;5.5 million
children ,20 years of age (;6% of the
U.S. population ,20 years) under sur-
veillance annually. Approximately 3.5
million children ,20 years of age were
under surveillance in 2001 at the six
SEARCH recruitment centers, with ap-
proximately the same number at the
five centers under surveillance in 2009.
Denominators representing the popula-
tion at risk for the geographic-based
sites use race-bridged postcensal esti-
mates of the nonmilitary, noninstitu-
tionalized midyear populations in the
center catchment areas. The health
plans use end-of-year membership rolls,
and Indian Health Service beneficiary
rolls provide American Indian site denom-
inators. Compared with U.S. Census data,
the SEARCH surveillance population is
similar to the U.S. youth population with
respect to race/ethnicity, age, household
income, and parental education (2).
Centers conduct active surveillance
under Health Insurance Portability and
Accountability Act waivers of consent
using networks of endocrinologists (pe-
diatric and adult), as well other health
care providers, hospitals, community
health centers, clinical and administra-
tive data systems, and electronic
medical records. Cases are determined
to be valid (diabetes is confirmed in the
medical record or by the referring physi-
cian), eligible (based on age, residence,
nonmilitary, noninstitutionalized, and
health plan membership at diagnosis
[health plan sites]), andunique (duplicates
are removed) locally and are then regis-
tered anonymously with the Coordinating
Center at Wake Forest University. A high
degree of case ascertainment (generally
.90%), for both type 1 and type 2 diabe-
tes has been obtained, estimated using
capture-recapture methods (2–4).
The cohort study was developed by
recruiting incident cases in 2002–2006,
2008, and 2012 that had a baseline visit
near diagnosis and at least 5 years of
diabetes duration at the cohort visit as-
sessment (Fig. 1). The cohort study will
allow estimates of the prevalence and
incidence of acute and chronic compli-
cations as well as the degree to which
processes of care impact glycemia,
blood pressure, and lipid control and
diabetes-related outcomes. A biospeci-
men repository has also been developed
and is available for the conduct of ancil-
lary studies.
Figure 1—Summary of the SEARCH study design. The registry began in 2001 measuring prevalence, which was repeated in 2009. Incidence has been
measured annually starting in 2002. Youth diagnosed in 2002–2006, 2008, and 2012 had a baseline in-person visit for measurement of diabetes
autoantibodies, albuminuria, BMI, cardiovascular risk factors, and sociodemographic, quality of care, and quality of life questionnaires. Youth with
baseline visits (incident cases in 2002–2005) were invited to return in 12, 24, and 60 months after their baseline visit for additional visits. Those with
a baseline visit and at least 5 years of duration were asked to join the cohort study, started in 2012, which added measures of early complications
(retinopathy, cardiac autonomic and peripheral neuropathy, and arterial stiffness). Future follow-up of the cohort is planned.
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STUDY FINDINGS
Diabetes Is Frequent Among U.S.
Youth, and Both Type 1 and Type 2
Diabetes Are Increasing in Most
Racial/Ethnic Populations and Sex
and Age Groups
The prevalence of all types of diabetes
was 1.8/1,000 youth in 2001 and was
2.2/1,000 youth in 2009, which trans-
lated to at least 154,000 children/youth
in the U.S. with diabetes in 2001 (5) and
at least 192,000 in 2009 (6). Overall, be-
tween 2001 and 2009, prevalence of
type 1 diabetes in youth increased by
21.1% (95% CI 15.6–27.0), with similar
increases for boys and girls and in most
racial/ethnic and age groups (2) (Fig. 2).
The prevalence of type 2 diabetes also
increased significantly over the same
time period by 30.5% (95% CI 17.3–
45.1), with increases observed in both
sexes, 10–14- and 15–19-year-olds, and
among Hispanic and non-Hispanic white
and African American youth (2). These
data on changes in type 2 are consistent
with smaller U.S. studies (7–11).
The incidence of diabetes (per
100,000/year) in 2002 to 2003 was
24.6/100,000/year (12), representing
;15,000 new patients every year with
type 1 diabetes and 3,700 with type 2
diabetes, increasing to 18,436 newly di-
agnosed type 1 and 5,089 with type 2
diabetes in 2008 to 2009 (13). Among
non-Hispanic white youth, the incidence
of type 1 diabetes increased by 2.7%
(95% CI 1.2–4.3) annually between
2002 and 2009. Significant increases
were observed among all age groups ex-
cept the youngest age group (0–4 years)
(14). These increases for non-Hispanic
whites are consistent with data world-
wide (15,16), with the highest increase
in the 0–4-year age group (5.4% per
year) (17), something not seen in
SEARCH results. The underlying factors
responsible for this increase have not
yet been identified. Potential trends in
incidence of type 1 and type 2 diabetes
among other racial/ethnic groups are
currently being explored.
Diabetes presents a significant bur-
den to the health of U.S. youth and
represents a major clinical and public
health challenge, especially with in-
creasing burden of both types of diabe-
tes in minority youth and unique
challenges in proper diagnosis and man-
agement (18), given excess obesity in
minorities.
Many Youth With Diabetes,
Particularly Those of Racial and
Ethnic Minority Groups, Are at Risk
for Acute and Chronic Complications
Over 50% of youth are hospitalized at
diabetes onset, and ;30% of children
newly diagnosed with diabetes present
with diabetic ketoacidosis (DKA) (19).
Prevalence of DKA at diagnosis was
three times higher among youth with
type 1 diabetes (29.4%) compared with
youth with type 2 diabetes (9.7%) and
was lowest in Asian/Pacific Islanders
(16.2%) and highest among Hispanics
(27.0%).
A substantial proportion of youth
with diabetes, particularly African
American and American Indian youth
and especially youth with type 2 dia-
betes, come from low-resourced
homes (60–70%) (20–24). Overweight
[85–94% of U.S. BMI distribution (25)]
and obesity ($95% of the U.S. BMI dis-
tribution) are common among youth
with type 2 diabetes regardless of
race/ethnicity (80–90%). However, a
surprisingly large proportion of youth
with type 1 diabetes (35–50%) were
also overweight or obese across all ra-
cial/ethnic groups (20–24). This high
rate of overweight/obesity is at least
partly due to low rates of physical ac-
tivity (26) and low consumption of
fruits and vegetables (27).
A significant proportion of youth
with diabetes, particularly those with
type 2 diabetes, have very poor glyce-
mic control (Table 1) (28): 17% of youth
with type 1 diabetes and 27% of youth
with type 2 diabetes had A1C levels
$9.5% ($80 mmol/mol). Minority
youth were significantly more likely to
have higher A1C levels compared with
non-Hispanic white youth, regardless of
diabetes type. Table 1 also shows that
cardiovascular disease risk factors were
also elevated, including high blood
pressure and dyslipidemia (29–31), el-
evated apolipoprotein B (apoB) levels
and small, dense LDL particles (32).
Early signs of kidney disease (33), reti-
nopathy (34), neuropathy (35,36), as
well as increased arterial stiffness
(37–39) were also identified. This was
especially true for youth with type 2
diabetes and for racial and ethnic mi-
nority youth with type 1 diabetes.
Youth with worse glycemic control
had poorer levels of each of these out-
comes. These data stress the need to
enhance screening efforts for risk fac-
tors and preclinical disease in these
Figure 2—Prevalence (per 1,000) of diabetes by type, sex, age group, and race/ethnic group in 2001 and 2009 (2). P values for change between years:
*P , 0.05; **P , 0.01; ***P , 0.001. AA, African American; AI, American Indian; API, Asian Pacific Islander; HISP, Hispanic; NHW, non-Hispanic
white.
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high-risk populations to delay the long-
term impact of these complications.
While Many Youth With Diabetes Are
Receiving Quality Care, a Significant
Proportion of Youth Who Are Racial/
Ethnic Minorities and “Emerging
Adults” Are Not
Optimal care is an important compo-
nent of successful long-term manage-
ment for youth with diabetes. While
there are high levels of adherence for
some diabetes care indicators such as
blood pressure checks (95%), urinary
protein tests (83%), and lipid assess-
ments (88%), approximately one-third
of youth had no documentation of eye
or A1C values at appropriate intervals
and therefore were not meeting the
American Diabetes Association (ADA)-
recommended screening for diabetic
control and complications (40). Partici-
pants $18 years old, particularly those
with type 2 diabetes, andminority youth
with type 1 diabetes had fewer tests of
all kinds performed. Challenges in the
transition from pediatric to adult care
were also observed. There was a ;2.5
times greater odds of poor glycemic
control among youth with type 1 transi-
tioning to adult care compared with
those who remained in pediatric care,
suggesting that this period requires a
high level of support to ensure success
(41). Importantly, using basal-bolus
therapies and higher frequency of glu-
cose monitoring were associated with
lower A1C in youth with type 1 diabetes
(42).
These data highlight the challenges as-
sociated with achieving recommended
goals for appropriate diabetes manage-
ment in youth and indicate that some
subgroups are particularly vulnerable.
A Simple Etiologic Classification of
Diabetes Type Is Possible for Youth-
Onset Diabetes
Because recognition of the broader
spectrum of diabetes in children and
adolescents is recent, there are no
gold-standard definitions for differenti-
ating the types of diabetes in this pop-
ulation, either for research or clinical
purposes or for public health surveil-
lance. The ADA classification of diabetes
as type 1 and type 2 does not include
operational definitions for the specific
etiologic markers of diabetes type,
such as types and numbers of diabetes
autoantibodies or measures of insulin
resistance, hallmarks of type 1 and 2 di-
abetes, respectively (43). Moreover,
obese adolescents with a clinical pheno-
type suggestive of type 2 diabetes can
present with ketoacidosis (44) or have
evidence of autoimmunity (45).
Using the ADA framework (43), we
operationalized definitions of two main
etiologic markers, autoimmunity and in-
sulin sensitivity, to identify four etio-
logic subgroups based on the presence
or absence of markers. Autoimmunity
was based on presence of one or more
diabetes autoantibodies (GAD65 and
IA2). Insulin sensitivity was estimated
using clinical variables (A1C, triglyceride
level, and waist circumference) from a
formula that was highly associated with
estimated insulin sensitivity measured
using a euglycemic-hyperinsulinemic
clamp among youth with type 1 and 2
and normal control subjects (46). Partic-
ipants were categorized as insulin resis-
tant (estimated insulin sensitivity
,8.15, representing the lowest 25th
percentile among National Health and
Nutrition Examination Survey youth)
and insulin sensitive (47). Using this ap-
proach, 54.5% of SEARCH cases were
classified as typical type 1 (autoimmune,
insulin-sensitive) diabetes, while 15.9%
were classified as typical type 2 (nonau-
toimmune, insulin-resistant) diabetes.
Cases thatwere classified as autoimmune
and insulin-resistant likely represent indi-
viduals with type 1 autoimmune diabetes
and concomitant obesity, a phenotype
becoming more prevalent as a result of
the recent increase in the frequency of
obesity, but is unlikely to be a distinct
etiologic entity. This is supported by the
following: 1) the phenotype represented
;26% of all autoimmune cases, a propor-
tion similar to that expected, given that the
definition of insulin resistance was based
on the lowest 25th percentile for the Na-
tional Health and Nutrition Examination
Survey, and 2) there was a similar preva-
lence and titers of diabetes autoantibodies
Table 1—Prevalence of elevated glycemia, CVD risk factors, and early
complications, SEARCH 2006–2013
Type 1 P value Type 2 P value
Glycemia (28) N = 3,947 N = 552
A1C $9.5% ($80 mmol/mol), all races (%) 16.8 26.6
Non-Hispanic white 12.3 ,0.0001* 12.2 ,0.0001*
African American 35.5 22.3
Hispanic 27.3 27.4
Asian Pacific Islander 26.0 36.4
American Indian 52.2 43.8
CVD risk factors†, age 10–19 years (30) N = 1,376 N = 63
Hypertension (%) 22.0 73.0
Elevated triglycerides (%) 14.0 65.0
Decreased HDL (%) 9.0 60.0
Increased waist circumference (%) 15.0 95.0
N = 2,657 N = 345
Elevated apoB (%) (32) 10.6 36.3 ,0.0001‡
Dense LDL (%) (32) 7.9 36.3
Retinopathy (34) N = 222 N = 43
Any (%) 17.0 42.0 0.40‡
Mild/moderate/proliferative (%) 2.7 16.3
Nephropathy (33) N = 2,885 N = 374
Elevated ACR $30 mg/mg (%) 9.2 22.2 ,0.0001‡
Neuropathy N = 329 N = 70
Peripheral neuropathy MNSE .2 (%) (35) 8.2 25.7 ,0.0001‡
Heart rate variability (%) (36) 211.6 0.003††
Arterial stiffness (37) N = 535 N = 60
Pulse wave velocity (m/sec) 5.3 6.4 ,0.01‡
BrachD (%/mmHg) 6.1 5.2 ,0.01‡
ACR, albumin/creatinine ratio; BrachD, brachial distensibility (lower is stiffer); CVD, cardiovascular
disease; MNSE, Michigan neuropathy screening examination; pulse wave velocity, carotid to
femoral (higher is stiffer). *Within type of diabetes. †Hypertension: diastolic blood pressure
$90th percentile for age, sex, and height or taking medication for high blood pressure;
triglycerides $110 mg/dL; HDL #40 mg/dL; waist $90th percentile for age, sex, and height;
apoB $100 mg/dL; dense LDL, relative flotation rate #0.237. ‡Between type of diabetes.
††Compared with nondiabetic control subjects, N = 354 type 1; 176 control subjects.
care.diabetesjournals.org Hamman and Associates 3339
and similar distribution of HLA DR-DQ
risk genotypes to those observed in the
typical type 1 case (autoimmune and in-
sulin sensitive), suggesting a similar con-
tribution of immune-mediated disease
processes (47).
Ten percent of SEARCH participants
had no evidence of either autoimmunity
or insulin resistance and thus require
additional testing, including additional
measurements of diabetes-related
autoantibodies (only two antibodies
were measured in SEARCH) as well as
testing for monogenic forms of diabetes
to clarify etiology. Among antibody-
negative youth, 8% of those tested
had a mutation in one or more of the
hepatocyte nuclear factor-1a (HNF-
1a), glucokinase, and HNF-4a genes,
an estimated monogenic diabetes pop-
ulation prevalence of at least 1.2% (48).
These findings allowed us to pro-
pose a straightforward clinical classifi-
cation scheme (Fig. 3) without a
requirement for a new etiologic cate-
gory (i.e., type 1.5 or double diabetes).
With some additional clinical data col-
lection (especially antibodies and
waist circumference), the vast major-
ity of cases can be readily classified.
A summary of major topics and refer-
ences from SEARCH and the ancillary
studies is shown in Table 2.
Future Challenges and Opportunities
SEARCH has begun to clarify gaps in the
understanding of diabetes among youth
but challenges remain. Type 1 diabetes
is not uncommon amongminority youth
as previously assumed, and type 2 dia-
betes is diagnosed among youth from all
racial/ethnic groups. Both type 1 and
type 2 diabetes are increasing over
time, signaling a major challenge for
the provision of health care resources.
While recent evidence suggests that
obesity rates may be plateauing among
youth (49), this will at best result in a
future plateauing of the rates of type 2
diabetes in this population, though not
necessarily disease burden. A recent
analysis suggests that given current
population projections and observed
trends, the number of youth with type 1
diabetes will nearly triple and type 2
diabetes prevalence will quadruple by
2050 (50).
Continued surveillance is needed to
answer important questions:
c Will type 1 diabetes incidence con-
tinue to rise across all race and eth-
nicity groups in the U.S., or will there
be a leveling off, as recently reported
in Scandinavia (51–53)?
c Will type 2 diabetes incidence rise
across all race and ethnicity groups
in the U.S., or will there be a plateau-
ing as obesity rates plateau?
Challenges to “sustainable” surveil-
lance (e.g., relatively inexpensive, rapid,
and more geographically diverse) must
be faced. There is frequent movement
of youth with diabetes between health
care providers and systems over short
time spans, making ascertainment, es-
pecially of type 2 diabetes, surprisingly
difficult. While implementation of elec-
tronic health record (EHR) systems is
rapidly occurring, the harmonization of
multiple data systems and the identifica-
tion of crucial information (e.g., date of
diagnosis and type of diabetes) remain
difficult (54). Absence of testing for di-
abetic antibodies and measurement of
waist circumference are also common
and limit the use of existing records.
The increasing use of EHRs may permit
easier surveillance, but substantial work
remains to realize significant efficiencies.
The SEARCH cohort study was de-
signed to explore the clinical evolution
of diabetes and its complications on a
sample of youth with type 1 and type 2
diabetes in contemporary care. Despite
current treatment options, the preva-
lence of poor glycemic control is high,
particularly among minority youth. Our
initial findings suggest that a substantial
number of youth with diabetes will de-
velop serious, debilitating complications
early in life, which is likely to have sig-
nificant implications for their quality of
life, as well as economic and health care
implications. An especially high burden
was noted among youth with type 2 di-
abetes, consistent with data from the
TODAY study (55–57), and youth of mi-
nority racial/ethnic groups. Therefore,
important questions remain:
c Are diabetic complications more fre-
quent in youth with type 2 than type 1
of similar race/ethnicity and diabetes
duration? Are such complications
more frequent in minority youth re-
gardless of diabetes type?
c Are there differences in the onset, di-
abetes duration, and clustering of
complications between type 1 and
type 2 diabetes?
c Do known risk factors explain ob-
served differences or must other fac-
tors be identified?
c Are the sequence and severity of di-
abetic complications similar in youth
with type 1 and type 2 diabetes, or are
different mechanisms involved?
c What will the impact be of the Afford-
able Care Act implementation on the
care of youth and young adults with
diabetes, particularly those with type 2
diabetes?
Figure 3—Proposed algorithm for classification of pediatric diabetes. Presence of any antibodies
indicates type 1 diabetes. Absence of antibodies and a large waist [or insulin sensitivity score
,8.15 units (47)] indicates type 2 diabetes. Individuals with no antibodies and a normal waist (or
insulin sensitivity score$8.15 units) require additional testing for potential monogenic forms of
diabetes or other defects. GADA, GAD antibody; IAA, insulin autoantibody; MODY, maturity-
onset diabetes of the young.
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CONCLUSIONS
Our findings to date have contributed
to a better understanding of the com-
plex nature of diabetes in youth; how-
ever, the increasing trends in the burden
of type 1 and type 2 diabetes suggest
that there is a pressing need to continue
high-level, comprehensive surveillance
efforts. Given the evidence of early com-
plications despite current therapeutic
approaches, continuing long-term follow-
up of youth with diabetes is necessary to
expand our understanding of its natural
history, so the most appropriate ap-
proaches to primary, secondary, and ter-
tiary prevention of diabetes and its
complications in youth can occur.
A listing of all SEARCH publications is
available at www.searchfordiabetes
.org. The Supplementary Data lists the
SEARCH investigators and staff at each
of the sites.
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Race/ethnicity–specific characteristics
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Weight-loss practices and weight-related issues (58)
Clinical, biochemical, and genetic findings
Glycemic control
Lipids and glycemic control (59)
Glycemic control and change in lipids (61)
Psychosocial burden and glycemic control (63)
HLA and genetics
HLA-associated phenotypes (60)
Time trends in HLA susceptibility among type 1 in Colorado (62)
Prevalence of MODY due to HNF1A, HNF4A, glucokinase (48), JDRF Monogenic Study*
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b-Cell function
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Metabolic and inflammatory links with depression (92)
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